Wave Life Sciences Ltd. (WVE)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 1 |
Ownership rank: | 662 |
% of all portfolios: | 0.009% |
History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
Q2  2024 | |||||
≡ | Lee Ainslie - Maverick Capital | Reduce 0.24% | 18,718 | 0.00 | |
Q1  2024 | |||||
≡ | Lee Ainslie - Maverick Capital | Reduce 8.99% | 759,725 | 0.09 | |
Q4  2023 | |||||
≡ | Lee Ainslie - Maverick Capital | Add 28.11% | 1,853,485 | 0.19 | |
Q3  2023 | |||||
≡ | Lee Ainslie - Maverick Capital | Reduce 0.04% | 2,459 | 0.00 | |
Q1  2023 | |||||
≡ | Lee Ainslie - Maverick Capital | Reduce 7.06% | 500,886 | 0.06 | |
Q4  2022 | |||||
≡ | Lee Ainslie - Maverick Capital | Reduce 9.07% | 707,555 | 0.12 | |
Q2  2022 | |||||
≡ | Lee Ainslie - Maverick Capital | Add 39.54% | 2,211,830 | 0.18 | |
Q4  2021 | |||||
≡ | Lee Ainslie - Maverick Capital | Add 75.16% | 2,400,000 | 0.09 | |
Q3  2021 | |||||
≡ | Lee Ainslie - Maverick Capital | Add 3.41% | 105,258 | 0.01 | |
Q2  2021 | |||||
≡ | Lee Ainslie - Maverick Capital | Add 0.16% | 4,930 | 0.00 | |
Q1  2021 | |||||
≡ | Lee Ainslie - Maverick Capital | Buy | 3,083,201 | 0.16 | |
Q1  2020 | |||||
≡ | Meridian Contrarian Fund | Sell 100.00% | 160,000 | 0.23 | |
Q4  2019 | |||||
≡ | Meridian Contrarian Fund | Reduce 24.53% | 52,000 | 0.07 | |
Q3  2019 | |||||
≡ | Meridian Contrarian Fund | Add 73.77% | 90,000 | 0.35 | |
Q2  2019 | |||||
≡ | Meridian Contrarian Fund | Buy | 122,000 | 0.59 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.